Alice Levis

Nov 15, 2023 | bioprocessonline.com | John F Cipollo |Nick Hutchinson |FUJIFILM Diosynth Biotechnologies |Alice Levis

Interested in bringing your monoclonal antibody from transfection to GMP drug substance in nine months? Join us for a panel discussion to explore our Accelerated mAb Development Program. Meet our experts who have developed our phase-appropriate and cost-effective program, which is scalable and integrates strategies for risk mitigation. Watch now. The lightning-fast rise of mRNA raised the need for manufacturing standards and consensus on product quality attributes and test methods.